CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

EXCELling in Left Main Intervention 2019 Guidelines on Diabetes, Pre-Diabetes and Cardiovascular Diseases developed in collaboration with the EASD ESC Clinical Practice Guidelines Efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and meta-analysis of randomized trials Impact of intravascular ultrasound guidance in routine percutaneous coronary intervention for conventional lesions: data from the EXCELLENT trial Active factor XI is associated with the risk of cardiovascular events in stable coronary artery disease patients Impact of Percutaneous Revascularization on Exercise Hemodynamics in Patients With Stable Coronary Disease Comparative effectiveness analysis of percutaneous coronary intervention versus coronary artery bypass grafting in patients with chronic kidney disease and unprotected left main coronary artery disease Membrane type 1 matrix metalloproteinase promotes LDL receptor shedding and accelerates the development of atherosclerosis Evolving concepts in the management of antithrombotic therapy in patients undergoing transcatheter aortic valve implantation Clinical and angiographic outcomes of patients treated with everolimus-eluting stents or first-generation Paclitaxel-eluting stents for unprotected left main disease
|<<... 124 125 126 127 128 129 130 ...>>|

Review Article2016 Apr;9(4):e003700.

JOURNAL：Circ Cardiovasc Interv. Article Link

Outcomes with intravascular ultrasound-guided stent implantation: a meta-analysis of randomized trials in the era of drug-eluting stents

Elgendy IY, Mahmoud AN, Bavry AA et al. Keywords: coronary artery disease; drug-eluting stents; meta-analysis; percutaneous coronary intervention; ultrasonography, interventional

FULL TEXT PDF

>CBS CBS 2019

> CBS 2019

> CBS 2019 注册

> CBS 2019 会议日程

> CBS 2019 学术征集

> CBS 2019 热点

 CBSMD

> CBSMD 网站注册

> 教育中心

> 荐读文献

> Top 10 阅读文献

> 文献导读
CBS 2019 CBS 2019 主席团 教育中心 科研动态
Copyright ⓒ CBS MD Nanjing China. All rights reserved. 京ICP备16025898号-11
联系我们| Top